Le Lézard
Classified in: Health
Subjects: AWD, VET

Cognosante Awarded Veterans Health Administration High Reliability Organization Support Contract


WASHINGTON, Feb. 6, 2020 /PRNewswire-PRWeb/ -- Cognosante has been awarded a contract to provide advisory and assistance services (A&AS) to the Veterans Health Administration (VHA) to facilitate its transformation into a high reliability organization (HRO). Under the blanket purchase agreement, Cognosante and its teaming partners will work with the VHA to conduct facilitated assessments of VA Medical Centers and develop and execute customized implementation plans to facilitate the establishment of HRO principles throughout. The team will also provide coaching, training, sustainment plans, and other support services. The award carries a total estimated contract value of $98 million.

This contract award reflects Cognosante's commitment to delivering solutions that optimize the quality of healthcare to our nation's Veterans. "We are proud to support the VHA ? the largest integrated healthcare system in the country - in its mission to provide Veterans with critical healthcare services in the most safe and reliable environments possible," says James Gordon, President of Cognosante.

Cognosante has partnered with several prominent organizations: Safe and Reliable Healthcare, the Institute for Safe Medication Practice, and Intermountain Healthcare, to support this contract. The entire project team includes, in addition to the aforementioned, Pharos Group, Inc., Tech Werks, Ipsos, Health Care Management Solutions, LLC., and Jeff Wright Consulting. "We are bringing a deep bench of seasoned experts who understand the complexity of healthcare delivery, at a leadership level, an organizational level, and at the front lines. This unique expertise positions us well to support the VHA in its high reliability journey," said Steve Schliesman, General Manager of Cognosante's Military and Veterans Health Business Unit.

The VHA is currently pursuing enterprise-wide high reliability organization transformation as part of a large-scale modernization effort. High Reliability Healthcare Organizations are committed to pursuing an environment of zero preventable harm. The requirements to achieve high reliability in healthcare can be summarized into three broad domains: leadership, process, and culture. Cognosante is currently supporting several modernization efforts at the VA, including the development of a community care referral and authorization system, and electronic health record development.

About Cognosante

Cognosante provides technology solutions and business process outsourcing to Federal, state, and local government health agencies. The company has more than three decades of experience working with 48 states and the Federal government, developing, managing, and executing large, complex health information programs. Its expertise includes Medicaid, Medicare, military and Veterans health, the health insurance marketplace, data standards and analytics, and modular system development and integration. Visit http://www.cognosante.com for more information.

 

SOURCE Cognosante


These press releases may also interest you

at 07:08
Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter...

at 07:05
Bruker Corporation is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second quarter of 2024. This ultra-high field NMR...

at 07:05
KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today...

at 07:05
Satellos Bioscience Inc. ("Satellos" or the "Company") , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced preliminary results from a single case...

at 07:00
ThirtyFiveBio Limited,...

at 07:00
DRI Healthcare Trust (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a second royalty interest in the worldwide net sales of Xenpozyme (olipudase alfa) from HLS...



News published on and distributed by: